Similar articles for PMID: 32030730

Year	Number of Results
1989	2
1990	2
1991	1
1993	1
1994	1
1995	1
1996	3
1999	1
2001	1
2002	4
2003	4
2004	2
2005	1
2006	4
2007	5
2008	4
2009	1
2010	5
2011	3
2012	7
2013	3
2014	5
2015	2
2016	5
2017	9
2018	3
2019	5
2020	6
2024	0

1

In search for a haemoglobin threshold in myelodysplastic syndromes.

Scheinberg P. Scheinberg P. Br J Haematol. 2020 Jun;189(5):813-814. doi: 10.1111/bjh.16392. Epub 2020 Feb 6. Br J Haematol. 2020. PMID: 32030730 Free article. No abstract available.

2

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.

Gu Y, Estcourt LJ, Doree C, Hopewell S, Vyas P. Gu Y, et al. Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD011577. doi: 10.1002/14651858.CD011577.pub2. Cochrane Database Syst Rev. 2015. PMID: 26436602 Free PMC article. Review.

3

Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials.

Mo A, McQuilten ZK, Wood EM, Weinkove R. Mo A, et al. Intern Med J. 2017 Jun;47(6):695-698. doi: 10.1111/imj.13434. Intern Med J. 2017. PMID: 28580745

4

The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.

Platzbecker U, Hofbauer LC, Ehninger G, Hölig K. Platzbecker U, et al. Leuk Res. 2012 May;36(5):525-36. doi: 10.1016/j.leukres.2012.01.006. Epub 2012 Feb 1. Leuk Res. 2012. PMID: 22300879 Review.

5

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.

Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C, Liu J, Nakamura R, Young NS, Barrett AJ. Molldrem JJ, et al. Ann Intern Med. 2002 Aug 6;137(3):156-63. doi: 10.7326/0003-4819-137-3-200208060-00007. Ann Intern Med. 2002. PMID: 12160363 Free article. Clinical Trial.

6

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.

Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, Parker J; UK MDS Guidelines Group. Bowen D, et al. Br J Haematol. 2003 Jan;120(2):187-200. doi: 10.1046/j.1365-2141.2003.03907.x. Br J Haematol. 2003. PMID: 12542475 Free article. No abstract available.

7

Managing myelodysplastic syndromes.

Kurtin S. Kurtin S. Oncology (Williston Park). 2007 Feb;21(2 Suppl Nurse Ed):45-6. Oncology (Williston Park). 2007. PMID: 17474364 Free article. No abstract available.

8

Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.

Moncharmont P, Quittançon E, Barday G, Benamara A; les Correspondants d'Hémovigilance et de sécurité transfusionnelle Auvergne Rhône Alpes. Moncharmont P, et al. Vox Sang. 2019 May;114(4):349-354. doi: 10.1111/vox.12765. Epub 2019 Feb 28. Vox Sang. 2019. PMID: 30818416

9

Myelodysplastic syndromes: a practical approach to diagnosis and treatment.

Barzi A, Sekeres MA. Barzi A, et al. Cleve Clin J Med. 2010 Jan;77(1):37-44. doi: 10.3949/ccjm.77a.09069. Cleve Clin J Med. 2010. PMID: 20048028 Free article. Review.

10

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.

Platzbecker U, Germing U, Götze KS, Kiewe P, Mayer K, Chromik J, Radsak M, Wolff T, Zhang X, Laadem A, Sherman ML, Attie KM, Giagounidis A. Platzbecker U, et al. Lancet Oncol. 2017 Oct;18(10):1338-1347. doi: 10.1016/S1470-2045(17)30615-0. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870615 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year